AHA: Lowering TGs with pemafibrate does not cut cardiovascular risk in type 2 diabetes
Nov 08, 2022
In patients with type 2 diabetes, hypertriglyceridemia and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo.
New instrument developed for assessing patient knowledge of CKD
Apr 04, 2022
KART 2.0 can differentiate patients who have spent less than one versus one or more hours speaking to health professionals, reading about transplantation.
Preventive aspirin should be based on benefit, not age
Jan 14, 2022
The authors urge primary care physicians to make case-by-case basis decisions based on the benefit-to-risk.
The ‘obesity paradox’ among seniors
By
Jill Carte
Dec 20, 2018
There are ways that senior living community executive directors and nursing home administrators can help residents under their care reduce their weight, if necessary.
Heart failure training increases home care worker job satisfaction: Cornell study
By
Joe Jancsurak
Nov 12, 2020
Home care workers who have been trained in heart failure are more satisfied with their jobs and feel more prepared and confident working with heart failure patients, according to new cross-campus research...
A fixed-dose combo with BP-lowering meds, statin and aspirin yields the largest reduction in cardiovascular risk.
COVID-19 vaccine priority populations vary by state, city: reports
By
Kimberly Bonvissuto
Dec 11, 2020
With the Food and Drug Administration’s vaccine advisory board recommending approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization on Thursday, two data analyses outline which...